focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Share News (DPH)

  • There is currently no data for DPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Rough PMIs, Gazprom send European stocks lower

Mon, 05th Sep 2022 12:15

(Alliance News) - Stock markets were being sold off on Monday, after Russia cut off gas supply via a key pipeline and a series of private sector surveys confirmed the damage being done to the European economy.

On Friday, Gazprom said that a gas pipeline to Germany - which was due to reopen at the weekend - would remain shut until a turbine is repaired, cutting off indefinitely an energy supply route to Europe.

"Predictably, wholesale gas prices are soaring, raising the prospect of even higher energy bills for businesses and consumers and sending the pound and the euro to new multi-year lows against the dollar," AJ Bell investment director Russ Mould said.

The euro traded at USD0.9936 midday Monday, down from USD1.0027 late Friday. Sterling was priced at USD1.1510, down from USD1.1575.

The UK will learn Monday who will be its next prime minister, with Liz Truss the favourite to succeed Boris Johnson and take charge as the country battles a spiralling cost-of-living crisis. The result will be announced at 1230 BST, after foreign minister Truss and her rival, former finance minister Rishi Sunak, spent the summer rallying support among the Conservative Party members who cast the final vote.

If she wins, Truss will become the UK's third female prime minister following Theresa May and Margaret Thatcher. The 47-year-old has consistently been ahead of 42-year-old Sunak in polling among the estimated 200,000 Tory members eligible to vote.

The FTSE 100 index was down 51.56 points, or 0.7%, at 7,229.63 midday Monday. The mid-cap FTSE 250 index was down 219.21 points, or 1.2%, at 18,634.01. The AIM All-Share index was down 5.08 points, or 0.6%, at 861.11.

The Cboe UK 100 index was down 0.7% at 722.49. The Cboe 250 was down 1.1% at 15,981.03, and the Cboe Small Companies down 0.3% at 13,682.72.

In mainland Europe, the CAC 40 in Paris was down 1.7%, while the DAX 40 in Frankfurt was 2.4% lower.

"Bullish market drivers are becoming increasingly difficult to find for stock traders, especially in Europe where the energy crisis ramped up again following Gazprom's decision to halt gas deliveries to the EU through one of its key pipelines, as a retaliation measure against the oil purchase price cap set up by leaders of the G7 nations," Pierre Veyret, technical analyst at ActivTrades, said.

"This decision added pressure to an already uncertain macro context and will likely continue to drive [equities] prices down in the short-term."

Brent oil was trading at USD95.51 a barrel, higher than USD94.00 late Friday.

Oil also was being bid up as the OPEC+ countries are expected to agree a modest increase in oil production at a meeting on Monday,

The 13 members of the Organization of the Petroleum Exporting Countries cartel, led by Saudi Arabia, and their 10 partners, led by Russia, are meeting to adjust their quotas for October. Talks were scheduled to start at 1200 BST.

Adding to the downbeat mood was a report showing the eurozone's private sector fell into decline in August, as a drop in demand and cost-of-living concerns led to weakness in business activity.

The S&P Global eurozone services purchasing managers' index swung down to 49.8 points from 51.2 points in July, passing below the neutral mark of 50.0 points to indicate a contraction. The reading for August marked a 17-month low.

As well, the UK services sector's growth slowed in August, as sales took a hit from growing economic uncertainty and reduced client confidence.

The headline seasonally adjusted S&P Global/Chartered Institute of Procurement UK services PMI business activity index fell to 50.9 points in August from 52.6 in July.

Despite being in growth territory, the print came in well short of market expectations, according to FXStreet, of 52.5.

S&P Global noted August's reading was the softest in 18 months.

In London, miners were in the green. Glencore was up 4.1%, Antofagasta 2.0%, Anglo American 1.1% and Rio Tinto was 1.0% higher.

Anchored to the bottom of the FTSE 100 was Dechra Pharmaceuticals, down 9.0%.

The veterinary products firm reported higher full-year profit and revenue, though it warned that growth rates are normalising as pandemic tailwinds ease.

In the financial year that ended June 30, Dechra reported revenue of GBP681.8 million, up 12% from GBP608.0 million the year before. Pretax profit increased 4.9% to GBP77.6 million, compared to GBP74.0 million in 2021.

With financial year 2022 revenue and profit rising, Dechra lifted its annual payout by 11% to 44.89p from 40.50p a year earlier.

However, Dechra noted that revenue in the second half of the year normalised to historic levels of growth, as the benefit of increased spending on pets seen during the Covid-19 restrictions slowed down.

Among London midcaps, Countryside Partnerships was the best performer, advancing 5.5%.

The housebuilder agreed to be acquired by peer Vistry Group.

The cash-and-shares deal, worth about GBP1.25 billion, values Countryside shares at 249 pence each, a 9.1% premium to its closing price on Friday.

Vistry is offering 0.255 of a share and 60 pence cash for each Countryside share. The merger is expected to close in the first quarter of 2023.

Vistry added it expects the combination to be return-on-capital-employed enhancing from 2024.

Countryside shareholders will own about 37% of enlarged firm. "The combination would create one of the country's leading homebuilders, comprising a top tier housebuilder and a leading partnerships business, with capability across all housing tenures, and delivering much needed affordable housing," Vistry explained.

Vistry expects the combined revenue to increase to over GBP3 billion per year, much higher than its medium term target of around GBP1.6 billion.

Vistry was 0.3% higher.

Heading in the opposite direction, sports car maker Aston Martin shed 9.9%.

It confirmed its plan for the launch of a rights issue to raise GBP575.8 million, supported by a fund controlled by Saudi Arabia's de facto leader.

Aston Martin noted Saudi Arabia's sovereign wealth fund, the Public Investment Fund, Lawrence Stroll's Yew Tree Consortium, and fellow car maker Mercedes-Benz are taking up their full entitlements, amounting to 45% of the total rights issue.

Aston will issue 559 million new shares as part of its rights issue, on the basis of four new shares for every one existing share. The shares will be issued at a price of 103 pence each, reflecting a 79% discount to the company's closing price on Friday last week at 480p.It was trading at 437.46p around midday on Monday.

Looking ahead to the open in New York, the Dow Jones Industrial Average is called up 0.4%, the S&P 500 is called up 0.3%, and the Nasdaq Composite is seen opening 0.1% higher.

Against the yen, the dollar was quoted at JPY140.48, up from JPY140.05.

Gold was quoted at USD1,714.10 an ounce early Monday, up from USD1,713.90 on late Friday.

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
12 Jan 2024 06:59

IN BRIEF: Persimmon to replace outbound FTSE 100 constituent Dechra

Persimmon PLC - York, England-based housebuilder - To rejoin FTSE 100 index on Tuesday as acquisition of Cheshire, England-based veterinary drug maker Dechra Pharmaceuticals PLC edges closer. Baillie Gifford US Growth Trust PLC will be added to the FTSE 250 index. The Dechra offers values the firm at around GBP4.5 billion.

Read more
27 Dec 2023 10:29

IN BRIEF: EU clears Dechra Pharmaceuticals takeover by EQT funds

Dechra Pharmaceuticals PLC - Cheshire, England-based veterinary drug maker - European Commission on Friday clears takeover of Dechra by funds managed by EQT Fund Management Sarl, together with Luxinva SA. As a result, all conditions of the offer relating to antitrust and regulatory approvals have been met. Takeover is expected to complete on January 16, and Dechra shares will be cancelled from trading in London from the market open the next day. The offer values Dechra at 3,875 pence per share, or about GBP4.5 billion in total.

Read more
6 Dec 2023 15:13

UK shareholder meetings calendar - next 7 days

Thursday 7 December 
Asia Dragon Trust PLCAGM
Bioventix PLCAGM
Darktrace PLCAGM
Doric Nimrod Air Two LtdAGM
essensys PLCAGM
Fidelity Emerging Markets LtdAGM
GS Chain PLCAGM
Haydale Graphene Industries PLCAGM
Kibo Energy PLCAGM
Kin & Carta PLCAGM
Lok'n Store Group PLCAGM
Parity Group PLCGM re sale of Parity Professionals to Network Ventures
Supermarket Income REIT PLCAGM
Westmount Energy LtdAGM
YouGov PLCAGM
Friday 8 December 
Amedeo Air Four Plus LtdAGM
Ashoka India Equity Investment Trust PLCAGM
Associated British Engineering PLCAGM
Associated British Foods PLCAGM
Corcel PLCGM re disposal of 41% interest in the Mambare nickel/cobalt project
Hargreaves Lansdown PLCAGM
URA Holdings PLCGM re closing the fundraise
Monday 11 December 
IamFire PLCAGM with vote on name change to WeCap PLC
Pharma C Investments PLCGM re allowing investments in fintech, AI sectors
SigmaRoc PLCGM re reverse takeover
Tribal Group PLCGM re cash offer by Tiger Bidco 1 Ltd
Vela Technologies PLCAGM
Tuesday 12 December 
Atalaya Mining PLCEGM re redomiciliation to Spain from Cyprus
Blackrock Greater Europe Investment Trust PLCAGM
Distil PLCGM re placing and subscription
Gelion PLCAGM
Wednesday 13 December 
Dechra Pharmaceuticals PLCAGM
Limitless Earth PLCAGM
Softcat PLCAGM
Volution Group PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
29 Nov 2023 09:19

IN BRIEF: Hargreaves Lansdown picks Dechra chair Alison Platt as chair

Hargreaves Lansdown PLC - Bristol, England-based wealth management platform - Hires Alison Platt, the current chair of Dechra Pharmaceuticals PLC, to be next its non-executive chair. Platt replaces Deanna Oppenheimer, who will leave the Hargreaves board at its annual general meeting on Friday next week, having been chair for six years. Platt will join the Hargreaves board in early 2024. Until regulatory approval for Platt, Senior Independent Director Penny James will be interim chair. Dechra, a veterinary drugmaker, has agreed to be taken over by EQT, which is a Swedish private equity firm, and Luxinva SA, which is controlled by the sovereign wealth fund of the United Arab Emirates. The GBP4.5 billion deal is expected to be completed by early 2024. Platt also is a non-executive director of grocer Tesco PLC and chair of general insurer Ageas (UK) Ltd. Previously, she led estate agent Countrywide as chief executive officer from 2014 to 2018.

Read more
29 Nov 2023 08:26

LONDON MARKET OPEN: FTSE 100 falls; Halfords, Xaar plunge

(Alliance News) - Stock prices in London opened mixed on Wednesday, as large caps fell on account of a stronger pound, though the domestically-focused midcap index rose.

Read more
29 Nov 2023 07:39

LONDON BRIEFING: Hargreaves Lansdown says Dechra's Platt to be chair

(Alliance News) - Stocks in London are expected to open lower on Wednesday, as investors consider the latest dovish remarks from the US Federal Reserve.

Read more
27 Nov 2023 08:44

Dechra Pharmaceuticals director steps down after 12 years

(Alliance News) - Dechra Pharmaceuticals PLC on Monday said Director Tony Griffin has stepped down after 12 years in the role, effective immediately.

Read more
27 Nov 2023 08:31

Tony Griffin stepping down as Dechra executive director

(Sharecast News) - Dechra Pharmaceuticals announced the departure of one of its longstanding executives, Tony Griffin, on Monday.

Read more
12 Oct 2023 09:03

TOP NEWS: Dechra Pharma swings to loss ahead of takeover by EQT

(Alliance News) - Dechra Pharmaceuticals PLC on Thursday said it swung to an annual loss as it lamented high inflation and cost of sales, despite growth in all pharmaceutical product categories.

Read more
12 Oct 2023 07:52

Dechra delivers 'resilient' year as EQT buyout nears completion

(Sharecast News) - London-listed veterinary pharmaceuticals group Dechra, which will soon be taken private after a buyout by Sweden's EQT, said on Thursday it delivered a "resilient" performance in the year to 30 June.

Read more
12 Oct 2023 07:45

LONDON BRIEFING: UK economy grows 0.2%; CMA probes ITV and BBC

(Alliance News) - Stocks in London are called higher on Thursday, following an upbeat trading session in Asia.

Read more
5 Oct 2023 15:46

UK earnings, trading statements calendar - next 7 days

Friday 6 October 
JD Wetherspoon PLCFull Year Results
Monday 9 October 
Sareum Holdings PLCFull Year Results
Tuesday 10 October 
1Spatial PLCHalf Year Results
EnSilica PLCFull Year Results
Reach PLCTrading Statement
Robert Walters PLCTrading Statement
ScS Group PLCFull Year Results
Target Healthcare REIT PLCFull Year Results
YouGov PLCFull Year Results
Wednesday 11 October 
discoverIE Group PLCTrading Statement
Eneraqua Technologies PLCFull Year Results
Jubilee Metals Group PLCFull Year Results
Marston's PLCTrading Statement
Netcall PLCFull Year Results
PageGroup PLCTrading Statement
QinetiQ Group PLCTrading Statement
Sanderson Design Group PLCHalf Year Results
Tharisa PLCTrading Statement
Thursday 12 October 
Atalaya Mining PLCTrading Statement
Brooks Macdonald Group PLCTrading Statement
Dechra Pharmaceuticals PLCFull Year Results
easyJet PLCTrading Statement
Hays PLCTrading Statement
Kenmare Resources PLCtrading Statement
N Brown Group PLCHalf Year Results
Norcros PLCTrading Statement
Treatt PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
4 Sep 2023 09:01

Permira to buy UK pharma services firm Ergomed for $886 mln

Sept 4 (Reuters) - European private equity firm, Permira, has agreed to buy British biopharmaceutical services company Ergomed for about 703.1 million pounds ($886.40 million), the two firms said on Monday, in the latest UK healthcare deal this year.

Read more
31 Aug 2023 07:49

LONDON BRIEFING: Stocks seen higher; Grafton begins another buyback

(Alliance News) - Stocks in London are set to open higher on Thursday as market focus turns to inflation and whether it is cooling enough to justify a pause in September from the European Central Bank and the US Federal Reserve.

Read more
30 Aug 2023 17:55

TOP NEWS: M&S returns to FTSE 100 after four years, Persimmon exits

(Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, September 18, after completing its quarterly review.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.